CTMXCytomX Therapeutics, Inc.
$2.19-48% 1Y
$2.19
$2.1252 weeks$6.75
Growth
Is CTMX growing?
CytomX Therapeutics, Inc.'s revenue has shrunk 47% a year over three years.
−47%
Revenue growth, 3-year annual rate · Biotechnology median +21% · compounded from trailing twelve-month revenue
- Years of annual history on file
- 13
Years of annual history on file · FY2013 to FY2025, as filed
Details›
- Revenue FY2021
- $37M
- Revenue FY2022
- $53M
- Revenue FY2023
- $101M
- Revenue FY2024
- $138M
- Revenue FY2025
- $76M
Annual income statements as filed with the SEC.
Biotechnology
The closest names by size in the same industry